IFI16 Restricts HSV-1 Replication by Accumulating on the HSV-1 Genome, Repressing HSV-1 Gene Expression, and Directly or Indirectly Modulating Histone Modifications

Interferon-γ inducible factor 16 (IFI16) is a multifunctional nuclear protein involved in transcriptional regulation, induction of interferon-β (IFN-β), and activation of the inflammasome response. It interacts with the sugar-phosphate backbone of dsDNA and modulates viral and cellular transcription...

Full description

Saved in:
Bibliographic Details
Published inPLoS pathogens Vol. 10; no. 11; p. e1004503
Main Authors Johnson, Karen E., Bottero, Virginie, Flaherty, Stephanie, Dutta, Sujoy, Singh, Vivek Vikram, Chandran, Bala
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 01.11.2014
Public Library of Science (PLoS)
Subjects
Biology and Life Sciences
Bone cancer
Cell Line, Tumor
Colleges & universities
Deoxyribonucleic acid
DNA
Experiments
Gene expression
Gene Expression Regulation, Viral
Genetic aspects
Genome, Viral
Genomes
Health aspects
HEK293 Cells
Herpes simplex virus
Herpes viruses
Herpesvirus 1, Human - physiology
Histones
Histones - genetics
Histones - metabolism
Humans
Infections
Interferon
Microscopy
Nuclear Proteins - genetics
Nuclear Proteins - metabolism
Phosphoproteins - genetics
Phosphoproteins - metabolism
Protein Processing, Post-Translational
Protein research
Proteins
RNA polymerase
Transcription factors
Viral Proteins - biosynthesis
Viral Proteins - genetics
Virus Replication
Virus research
Online AccessGet full text
ISSN1553-7374
1553-7366
1553-7374
DOI10.1371/journal.ppat.1004503

Cover

Abstract Interferon-γ inducible factor 16 (IFI16) is a multifunctional nuclear protein involved in transcriptional regulation, induction of interferon-β (IFN-β), and activation of the inflammasome response. It interacts with the sugar-phosphate backbone of dsDNA and modulates viral and cellular transcription through largely undetermined mechanisms. IFI16 is a restriction factor for human cytomegalovirus (HCMV) and herpes simplex virus (HSV-1), though the mechanisms of HSV-1 restriction are not yet understood. Here, we show that IFI16 has a profound effect on HSV-1 replication in human foreskin fibroblasts, osteosarcoma cells, and breast epithelial cancer cells. IFI16 knockdown increased HSV-1 yield 6-fold and IFI16 overexpression reduced viral yield by over 5-fold. Importantly, HSV-1 gene expression, including the immediate early proteins, ICP0 and ICP4, the early proteins, ICP8 and TK, and the late proteins gB and Us11, was reduced in the presence of IFI16. Depletion of the inflammasome adaptor protein, ASC, or the IFN-inducing transcription factor, IRF-3, did not affect viral yield. ChIP studies demonstrated the presence of IFI16 bound to HSV-1 promoters in osteosarcoma (U2OS) cells and fibroblasts. Using CRISPR gene editing technology, we generated U2OS cells with permanent deletion of IFI16 protein expression. ChIP analysis of these cells and wild-type (wt) U2OS demonstrated increased association of RNA polymerase II, TATA binding protein (TBP) and Oct1 transcription factors with viral promoters in the absence of IFI16 at different times post infection. Although IFI16 did not alter the total histone occupancy at viral or cellular promoters, its absence promoted markers of active chromatin and decreased those of repressive chromatin with viral and cellular gene promoters. Collectively, these studies for the first time demonstrate that IFI16 prevents association of important transcriptional activators with wt HSV-1 promoters and suggest potential mechanisms of IFI16 restriction of wt HSV-1 replication and a direct or indirect role for IFI16 in histone modification.
AbstractList Interferon-γ inducible factor 16 (IFI16) is a multifunctional nuclear protein involved in transcriptional regulation, induction of interferon-β (IFN-β), and activation of the inflammasome response. It interacts with the sugar-phosphate backbone of dsDNA and modulates viral and cellular transcription through largely undetermined mechanisms. IFI16 is a restriction factor for human cytomegalovirus (HCMV) and herpes simplex virus (HSV-1), though the mechanisms of HSV-1 restriction are not yet understood. Here, we show that IFI16 has a profound effect on HSV-1 replication in human foreskin fibroblasts, osteosarcoma cells, and breast epithelial cancer cells. IFI16 knockdown increased HSV-1 yield 6-fold and IFI16 overexpression reduced viral yield by over 5-fold. Importantly, HSV-1 gene expression, including the immediate early proteins, ICP0 and ICP4, the early proteins, ICP8 and TK, and the late proteins gB and Us11, was reduced in the presence of IFI16. Depletion of the inflammasome adaptor protein, ASC, or the IFN-inducing transcription factor, IRF-3, did not affect viral yield. ChIP studies demonstrated the presence of IFI16 bound to HSV-1 promoters in osteosarcoma (U2OS) cells and fibroblasts. Using CRISPR gene editing technology, we generated U2OS cells with permanent deletion of IFI16 protein expression. ChIP analysis of these cells and wild-type (wt) U2OS demonstrated increased association of RNA polymerase II, TATA binding protein (TBP) and Oct1 transcription factors with viral promoters in the absence of IFI16 at different times post infection. Although IFI16 did not alter the total histone occupancy at viral or cellular promoters, its absence promoted markers of active chromatin and decreased those of repressive chromatin with viral and cellular gene promoters. Collectively, these studies for the first time demonstrate that IFI16 prevents association of important transcriptional activators with wt HSV-1 promoters and suggest potential mechanisms of IFI16 restriction of wt HSV-1 replication and a direct or indirect role for IFI16 in histone modification.Interferon-γ inducible factor 16 (IFI16) is a multifunctional nuclear protein involved in transcriptional regulation, induction of interferon-β (IFN-β), and activation of the inflammasome response. It interacts with the sugar-phosphate backbone of dsDNA and modulates viral and cellular transcription through largely undetermined mechanisms. IFI16 is a restriction factor for human cytomegalovirus (HCMV) and herpes simplex virus (HSV-1), though the mechanisms of HSV-1 restriction are not yet understood. Here, we show that IFI16 has a profound effect on HSV-1 replication in human foreskin fibroblasts, osteosarcoma cells, and breast epithelial cancer cells. IFI16 knockdown increased HSV-1 yield 6-fold and IFI16 overexpression reduced viral yield by over 5-fold. Importantly, HSV-1 gene expression, including the immediate early proteins, ICP0 and ICP4, the early proteins, ICP8 and TK, and the late proteins gB and Us11, was reduced in the presence of IFI16. Depletion of the inflammasome adaptor protein, ASC, or the IFN-inducing transcription factor, IRF-3, did not affect viral yield. ChIP studies demonstrated the presence of IFI16 bound to HSV-1 promoters in osteosarcoma (U2OS) cells and fibroblasts. Using CRISPR gene editing technology, we generated U2OS cells with permanent deletion of IFI16 protein expression. ChIP analysis of these cells and wild-type (wt) U2OS demonstrated increased association of RNA polymerase II, TATA binding protein (TBP) and Oct1 transcription factors with viral promoters in the absence of IFI16 at different times post infection. Although IFI16 did not alter the total histone occupancy at viral or cellular promoters, its absence promoted markers of active chromatin and decreased those of repressive chromatin with viral and cellular gene promoters. Collectively, these studies for the first time demonstrate that IFI16 prevents association of important transcriptional activators with wt HSV-1 promoters and suggest potential mechanisms of IFI16 restriction of wt HSV-1 replication and a direct or indirect role for IFI16 in histone modification.
Interferon-γ inducible factor 16 (IFI16) is a multifunctional nuclear protein involved in transcriptional regulation, induction of interferon-β (IFN-β), and activation of the inflammasome response. It interacts with the sugar-phosphate backbone of dsDNA and modulates viral and cellular transcription through largely undetermined mechanisms. IFI16 is a restriction factor for human cytomegalovirus (HCMV) and herpes simplex virus (HSV-1), though the mechanisms of HSV-1 restriction are not yet understood. Here, we show that IFI16 has a profound effect on HSV-1 replication in human foreskin fibroblasts, osteosarcoma cells, and breast epithelial cancer cells. IFI16 knockdown increased HSV-1 yield 6-fold and IFI16 overexpression reduced viral yield by over 5-fold. Importantly, HSV-1 gene expression, including the immediate early proteins, ICP0 and ICP4, the early proteins, ICP8 and TK, and the late proteins gB and Us11, was reduced in the presence of IFI16. Depletion of the inflammasome adaptor protein, ASC, or the IFN-inducing transcription factor, IRF-3, did not affect viral yield. ChIP studies demonstrated the presence of IFI16 bound to HSV-1 promoters in osteosarcoma (U2OS) cells and fibroblasts. Using CRISPR gene editing technology, we generated U2OS cells with permanent deletion of IFI16 protein expression. ChIP analysis of these cells and wild-type (wt) U2OS demonstrated increased association of RNA polymerase II, TATA binding protein (TBP) and Oct1 transcription factors with viral promoters in the absence of IFI16 at different times post infection. Although IFI16 did not alter the total histone occupancy at viral or cellular promoters, its absence promoted markers of active chromatin and decreased those of repressive chromatin with viral and cellular gene promoters. Collectively, these studies for the first time demonstrate that IFI16 prevents association of important transcriptional activators with wt HSV-1 promoters and suggest potential mechanisms of IFI16 restriction of wt HSV-1 replication and a direct or indirect role for IFI16 in histone modification.
  Interferon-γ inducible factor 16 (IFI16) is a multifunctional nuclear protein involved in transcriptional regulation, induction of interferon-β (IFN-β), and activation of the inflammasome response. It interacts with the sugar-phosphate backbone of dsDNA and modulates viral and cellular transcription through largely undetermined mechanisms. IFI16 is a restriction factor for human cytomegalovirus (HCMV) and herpes simplex virus (HSV-1), though the mechanisms of HSV-1 restriction are not yet understood. Here, we show that IFI16 has a profound effect on HSV-1 replication in human foreskin fibroblasts, osteosarcoma cells, and breast epithelial cancer cells. IFI16 knockdown increased HSV-1 yield 6-fold and IFI16 overexpression reduced viral yield by over 5-fold. Importantly, HSV-1 gene expression, including the immediate early proteins, ICP0 and ICP4, the early proteins, ICP8 and TK, and the late proteins gB and Us11, was reduced in the presence of IFI16. Depletion of the inflammasome adaptor protein, ASC, or the IFN-inducing transcription factor, IRF-3, did not affect viral yield. ChIP studies demonstrated the presence of IFI16 bound to HSV-1 promoters in osteosarcoma (U2OS) cells and fibroblasts. Using CRISPR gene editing technology, we generated U2OS cells with permanent deletion of IFI16 protein expression. ChIP analysis of these cells and wild-type (wt) U2OS demonstrated increased association of RNA polymerase II, TATA binding protein (TBP) and Oct1 transcription factors with viral promoters in the absence of IFI16 at different times post infection. Although IFI16 did not alter the total histone occupancy at viral or cellular promoters, its absence promoted markers of active chromatin and decreased those of repressive chromatin with viral and cellular gene promoters. Collectively, these studies for the first time demonstrate that IFI16 prevents association of important transcriptional activators with wt HSV-1 promoters and suggest potential mechanisms of IFI16 restriction of wt HSV-1 replication and a direct or indirect role for IFI16 in histone modification.
Interferon-γ inducible factor 16 (IFI16) is a multifunctional nuclear protein involved in transcriptional regulation, induction of interferon-β (IFN-β), and activation of the inflammasome response. It interacts with the sugar-phosphate backbone of dsDNA and modulates viral and cellular transcription through largely undetermined mechanisms. IFI16 is a restriction factor for human cytomegalovirus (HCMV) and herpes simplex virus (HSV-1), though the mechanisms of HSV-1 restriction are not yet understood. Here, we show that IFI16 has a profound effect on HSV-1 replication in human foreskin fibroblasts, osteosarcoma cells, and breast epithelial cancer cells. IFI16 knockdown increased HSV-1 yield 6-fold and IFI16 overexpression reduced viral yield by over 5-fold. Importantly, HSV-1 gene expression, including the immediate early proteins, ICP0 and ICP4, the early proteins, ICP8 and TK, and the late proteins gB and Us11, was reduced in the presence of IFI16. Depletion of the inflammasome adaptor protein, ASC, or the IFN-inducing transcription factor, IRF-3, did not affect viral yield. ChIP studies demonstrated the presence of IFI16 bound to HSV-1 promoters in osteosarcoma (U2OS) cells and fibroblasts. Using CRISPR gene editing technology, we generated U2OS cells with permanent deletion of IFI16 protein expression. ChIP analysis of these cells and wild-type (wt) U2OS demonstrated increased association of RNA polymerase II, TATA binding protein (TBP) and Oct1 transcription factors with viral promoters in the absence of IFI16 at different times post infection. Although IFI16 did not alter the total histone occupancy at viral or cellular promoters, its absence promoted markers of active chromatin and decreased those of repressive chromatin with viral and cellular gene promoters. Collectively, these studies for the first time demonstrate that IFI16 prevents association of important transcriptional activators with wt HSV-1 promoters and suggest potential mechanisms of IFI16 restriction of wt HSV-1 replication and a direct or indirect role for IFI16 in histone modification. HSV-1, a ubiquitous human pathogen that establishes a life-long infection, has evolved several mechanisms to evade host immune detection and responses. However, it is still subject to regulation by cellular factors. Recently, a host nuclear protein, IFI16, was shown to be involved in the innate defense response to HSV-1 infection. Here, we provide the first evidence that IFI16 inhibits wild-type HSV-1 replication by repressing viral gene expression independent of its roles in the immune response. We show that IFI16 binds the HSV-1 genome at the transcription start sites of several HSV-1 genes. Using a permanently IFI16-negative cell line that we generated, we demonstrate that IFI16 reduces the association of important transcription factors. IFI16 also promotes global histone modifications by increasing the markers of repressive chromatin and decreasing the markers for activating chromatin on viral and cellular genes. These insights into the role of IFI16 in HSV-1 biology suggest that stabilization of IFI16 is an attractive avenue for antiviral drug development.
Audience Academic
Author Bottero, Virginie
Dutta, Sujoy
Singh, Vivek Vikram
Johnson, Karen E.
Flaherty, Stephanie
Chandran, Bala
AuthorAffiliation H.M. Bligh Cancer Research Laboratories, Department of Microbiology and Immunology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States of America
University of Glasgow, United Kingdom
AuthorAffiliation_xml – name: H.M. Bligh Cancer Research Laboratories, Department of Microbiology and Immunology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, Illinois, United States of America
– name: University of Glasgow, United Kingdom
Author_xml – sequence: 1
  givenname: Karen E.
  surname: Johnson
  fullname: Johnson, Karen E.
– sequence: 2
  givenname: Virginie
  surname: Bottero
  fullname: Bottero, Virginie
– sequence: 3
  givenname: Stephanie
  surname: Flaherty
  fullname: Flaherty, Stephanie
– sequence: 4
  givenname: Sujoy
  surname: Dutta
  fullname: Dutta, Sujoy
– sequence: 5
  givenname: Vivek Vikram
  surname: Singh
  fullname: Singh, Vivek Vikram
– sequence: 6
  givenname: Bala
  surname: Chandran
  fullname: Chandran, Bala
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25375629$$D View this record in MEDLINE/PubMed
BookMark eNqVk9tu1DAQhiNURA_wBggicQNSd_Ehide9QFqVthupgNQCt5bjTLauEnuxHdR9Hx4Up5utugghkVzEnvn-P-PDHCZ7xhpIkpcYTTFl-P2t7Z2R7XS1kmGKEcpyRJ8kBzjP6YRRlu09Gu8nh97fRgZTXDxL9klOWV4QfpD8Ks9LXKRX4IPTKvh0cf19guN81Wolg7YmrdbpXKm-69s4N8s0hsINjOAFGNvB8SBw4P2Qf0hAena3iVpznEpTpx-1AxXadWpdWpp6O_tk6635QvsQ1zmEdDNW4J8nTxvZengxfo-Sb-dnX08Xk8svF-Xp_HKiCs7DRKoq4zUBiRtEKJINJYghhjOoSc0ZR4XEGAqeEVrRPG8AKsJYzjCrKkaLGT1KXm98V631YtxgL3AxywknlA9EuSFqK2_FyulOurWwUov7gHVLIV3QqgXBID4NwbxCsQJUVRwIqwiWhGcxUkSvD-Pf-qqDWoEJTrY7prsZo2_E0v4UGYmrm6Fo8HY0cPZHH09QdNoraFtpwPZD3YSgPK6bRvTNBl3KWJo2jY2OasDFnHKa4xniOFLTv1DxraHTKh5Lo2N8R_BuRxCZAHdhKXvvRXl99R_s51321eOtediT7b2NwMkGUM5676ARSof7yxIr1q3ASAxNsj1DMTSJGJskirM_xFv_f8p-AzP8FiU
CitedBy_id crossref_primary_10_3390_jcm8091408
crossref_primary_10_1007_s00430_019_00582_0
crossref_primary_10_1128_jvi_01028_22
crossref_primary_10_3390_pathogens6020024
crossref_primary_10_1155_2015_593757
crossref_primary_10_1073_pnas_1919133117
crossref_primary_10_1371_journal_ppat_1006769
crossref_primary_10_1371_journal_ppat_1005953
crossref_primary_10_2139_ssrn_4073010
crossref_primary_10_2217_fvl_2017_0109
crossref_primary_10_3390_v12050495
crossref_primary_10_1186_s12985_016_0518_2
crossref_primary_10_1371_journal_ppat_1005950
crossref_primary_10_1128_JVI_00006_17
crossref_primary_10_1371_journal_ppat_1005030
crossref_primary_10_1586_14789450_2016_1147353
crossref_primary_10_1016_j_bbrc_2023_05_049
crossref_primary_10_1016_j_it_2024_04_009
crossref_primary_10_3390_v10060291
crossref_primary_10_7554_eLife_49500
crossref_primary_10_1016_j_antiviral_2019_104546
crossref_primary_10_1016_j_antiviral_2021_105103
crossref_primary_10_1186_s12985_017_0891_5
crossref_primary_10_1016_j_chom_2019_05_002
crossref_primary_10_3390_pathogens12030437
crossref_primary_10_3390_molecules24030481
crossref_primary_10_3390_v14102113
crossref_primary_10_1128_cmr_00006_24
crossref_primary_10_1186_s13567_022_01077_2
crossref_primary_10_1016_j_immuni_2020_06_014
crossref_primary_10_1128_mBio_02574_19
crossref_primary_10_1016_j_virol_2015_02_009
crossref_primary_10_1126_sciadv_abg6680
crossref_primary_10_18632_oncotarget_16440
crossref_primary_10_3390_biom10121591
crossref_primary_10_3390_v9080218
crossref_primary_10_3390_microorganisms7060183
crossref_primary_10_3389_fimmu_2021_735643
crossref_primary_10_1016_j_it_2024_07_010
crossref_primary_10_1371_journal_ppat_1005019
crossref_primary_10_1016_j_virol_2015_04_003
crossref_primary_10_1128_mBio_02621_18
crossref_primary_10_1038_s41579_020_0382_3
crossref_primary_10_1074_mcp_M114_047068
crossref_primary_10_1128_JVI_00939_16
crossref_primary_10_1371_journal_ppat_1008752
crossref_primary_10_3390_v16020183
crossref_primary_10_1371_journal_ppat_1007667
crossref_primary_10_1128_mBio_01553_16
crossref_primary_10_3390_ijms252212346
crossref_primary_10_1073_pnas_2218825120
crossref_primary_10_1128_mBio_00944_17
crossref_primary_10_1128_mBio_01428_19
crossref_primary_10_7554_eLife_65243
crossref_primary_10_1128_MMBR_00099_20
crossref_primary_10_1016_j_tim_2016_11_009
crossref_primary_10_1371_journal_ppat_1009281
crossref_primary_10_1128_jvi_00110_24
crossref_primary_10_1016_j_coi_2022_102250
crossref_primary_10_1007_s13365_020_00852_1
crossref_primary_10_1002_jmv_70118
crossref_primary_10_3390_v12121464
crossref_primary_10_1073_pnas_2310996120
crossref_primary_10_15252_msb_20145808
crossref_primary_10_1080_14787210_2019_1656064
crossref_primary_10_1128_JVI_02249_15
crossref_primary_10_3390_v13071373
crossref_primary_10_1016_j_sbi_2016_01_011
crossref_primary_10_1038_ncomms14605
crossref_primary_10_1038_s41564_021_00907_x
crossref_primary_10_1007_s40588_016_0043_5
crossref_primary_10_1016_j_chom_2016_08_002
crossref_primary_10_3390_ijms23116171
crossref_primary_10_1186_s12985_016_0516_4
crossref_primary_10_1007_s13402_019_00472_w
crossref_primary_10_1016_j_celrep_2023_112341
crossref_primary_10_1038_cmi_2015_35
crossref_primary_10_3390_v16060877
crossref_primary_10_1016_j_molcel_2019_09_023
crossref_primary_10_3389_fcimb_2021_647992
crossref_primary_10_2478_am_2023_0009
crossref_primary_10_3389_fimmu_2020_624556
crossref_primary_10_1093_nar_gkad449
crossref_primary_10_3390_v8100290
crossref_primary_10_1089_dna_2017_3668
crossref_primary_10_1128_JVI_00013_15
crossref_primary_10_3389_fcimb_2022_814307
crossref_primary_10_3390_v14040666
crossref_primary_10_1111_imr_12893
crossref_primary_10_3389_fimmu_2020_613799
crossref_primary_10_1128_JVI_03160_15
crossref_primary_10_7554_eLife_11721
crossref_primary_10_1074_jbc_R115_652289
crossref_primary_10_1371_journal_pone_0207358
crossref_primary_10_1016_j_virol_2015_01_026
crossref_primary_10_1128_JVI_01003_16
crossref_primary_10_1371_journal_ppat_1007113
crossref_primary_10_3390_v13091836
crossref_primary_10_1016_j_ymeth_2015_04_004
crossref_primary_10_15252_embr_201845737
crossref_primary_10_1186_s12985_016_0495_5
crossref_primary_10_1155_2018_5214187
crossref_primary_10_1016_j_omtn_2022_11_025
crossref_primary_10_1083_jcb_202304106
crossref_primary_10_3390_v13040681
crossref_primary_10_1128_mBio_00098_16
crossref_primary_10_1016_j_virol_2020_10_013
crossref_primary_10_3389_fmicb_2019_02611
crossref_primary_10_1128_msystems_00198_22
crossref_primary_10_1128_JVI_00057_18
crossref_primary_10_1038_s44321_024_00046_w
crossref_primary_10_1371_journal_ppat_1005967
crossref_primary_10_1016_j_imbio_2017_07_002
crossref_primary_10_1080_21505594_2024_2425744
crossref_primary_10_1128_JVI_00099_17
crossref_primary_10_1016_j_cyto_2020_155025
crossref_primary_10_1002_eji_202048975
crossref_primary_10_1128_jvi_01549_24
crossref_primary_10_1515_labmed_2021_0173
Cites_doi 10.1379/1466-1268(1997)002<0119:HSVUPE>2.3.CO;2
10.1128/JVI.01581-13
10.1016/0042-6822(88)90637-X
10.1073/pnas.92.4.1008
10.1038/ni.1932
10.1128/JVI.78.18.9689-9696.2004
10.1126/science.1232033
10.1126/science.1243640
10.1371/journal.ppat.1002498
10.1016/j.virol.2008.01.001
10.4161/cc.10.24.18723
10.1016/j.virol.2009.09.021
10.1006/viro.2000.0275
10.1016/j.bbagrm.2014.02.013
10.1073/pnas.1203447109
10.1006/meth.2001.1262
10.1371/journal.pone.0002277
10.1016/j.chom.2014.03.004
10.1073/pnas.0505850102
10.1038/nprot.2006.37
10.1128/JVI.77.17.9192-9203.2003
10.1128/MCB.19.12.8393
10.1128/JVI.72.11.8620-8626.1998
10.1073/pnas.89.9.3952
10.1128/JVI.78.14.7818-7822.2004
10.1128/JVI.00139-10
10.1128/JVI.78.16.8411-8420.2004
10.1128/JVI.06713-11
10.1128/MCB.18.5.2876
10.1016/j.virol.2006.10.028
10.1152/ajplung.00363.2002
10.1006/viro.2001.0941
10.1074/jbc.M208911200
10.1016/j.stem.2014.04.020
10.1128/JVI.00805-13
10.1371/journal.pone.0019532
10.1038/nature07725
10.1074/jbc.M412604200
10.1128/JVI.07071-11
10.1128/JVI.71.8.6049-6054.1997
10.1007/BF00177824
10.1016/j.chom.2013.10.007
10.1128/JVI.03282-12
10.1128/JVI.00384-14
10.1128/JVI.14.1.8-19.1974
10.1099/0022-1317-69-12-3107
10.1007/BF00218044
10.1038/sj.onc.1207057
10.1073/pnas.1211302109
10.1074/jbc.M400344200
10.1074/jbc.M610943200
10.1186/2042-4280-3-6
10.2741/2673
10.1128/JVI.02474-13
10.1089/jir.1998.18.947
10.1128/JVI.02459-07
10.1016/S0140-6736(02)07681-X
10.1073/pnas.0707266104
10.1128/JVI.78.8.4185-4196.2004
10.1128/JVI.69.10.6249-6258.1995
10.1128/JVI.00082-13
10.1016/j.chom.2011.04.008
10.1074/jbc.M308012200
10.1016/j.immuni.2012.02.014
10.2353/ajpath.2006.050345
10.1128/JVI.43.1.314-324.1982
10.1016/j.bbrc.2012.05.065
10.1016/S0092-8674(00)00188-4
10.1016/j.stem.2014.06.011
10.1128/JVI.16.5.1308-1326.1975
10.1371/journal.pone.0008569
10.2741/2674
10.1099/0022-1317-75-6-1223
10.1158/0008-5472.CAN-13-2020
10.1038/317179a0
10.1073/pnas.1311669110
10.1128/JVI.00115-11
10.1128/JVI.78.18.10178-10186.2004
10.1128/JVI.01727-09
10.1186/1743-422X-1-5
10.1128/JVI.00613-08
10.1128/JVI.01575-08
10.1038/ni.2118
10.1073/pnas.84.7.1926
10.1001/jama.1982.03320280037026
10.1128/JVI.63.2.943-947.1989
10.1128/JVI.00385-11
10.1073/pnas.1323414111
10.1016/S0167-5699(97)01114-6
10.1128/MCB.19.9.5833
10.1083/jcb.150.1.13
10.1074/jbc.273.27.17172
10.1038/sj.onc.1204005
10.1128/JVI.01158-12
10.1128/JVI.01050-10
10.1038/nbt.2889
10.1128/JVI.03126-13
10.1128/JVI.63.5.1897-1906.1989
10.1038/nbt0502-473
10.1073/pnas.1316194110
ContentType Journal Article
Copyright COPYRIGHT 2014 Public Library of Science
2014 Johnson et al 2014 Johnson et al
2014 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Johnson KE, Bottero V, Flaherty S, Dutta S, Singh VV, Chandran B (2014) IFI16 Restricts HSV-1 Replication by Accumulating on the HSV-1 Genome, Repressing HSV-1 Gene Expression, and Directly or Indirectly Modulating Histone Modifications. PLoS Pathog 10(11): e1004503. doi:10.1371/journal.ppat.1004503
Copyright_xml – notice: COPYRIGHT 2014 Public Library of Science
– notice: 2014 Johnson et al 2014 Johnson et al
– notice: 2014 Public Library of Science. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited: Johnson KE, Bottero V, Flaherty S, Dutta S, Singh VV, Chandran B (2014) IFI16 Restricts HSV-1 Replication by Accumulating on the HSV-1 Genome, Repressing HSV-1 Gene Expression, and Directly or Indirectly Modulating Histone Modifications. PLoS Pathog 10(11): e1004503. doi:10.1371/journal.ppat.1004503
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISN
ISR
7X8
5PM
DOA
DOI 10.1371/journal.ppat.1004503
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Canada
Gale In Context: Science
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Full Text
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Restriction of HSV-1 Replication by IFI16
EISSN 1553-7374
ExternalDocumentID 1685292398
oai_doaj_org_article_7eeeef219b014e0bb9e27b21a2940146
PMC4223080
A393518091
25375629
10_1371_journal_ppat_1004503
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: CA 180758
– fundername: NCI NIH HHS
  grantid: R01 CA180758
GroupedDBID ---
123
29O
2WC
53G
5VS
7X7
88E
8FE
8FH
8FI
8FJ
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
B0M
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAP
EAS
EBD
EMK
EMOBN
ESX
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
ISN
ISR
ITC
KQ8
LK8
M1P
M48
M7P
MM.
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
QF4
QN7
RNS
RPM
SV3
TR2
TUS
UKHRP
WOW
~8M
3V.
CGR
CUY
CVF
ECM
EIF
H13
IPNFZ
M~E
NPM
PV9
RIG
RZL
WOQ
PMFND
7X8
PJZUB
PPXIY
PQGLB
PUEGO
5PM
-
AAPBV
ABPTK
ADACO
BBAFP
PQEST
PQUKI
PRINS
ID FETCH-LOGICAL-c699t-acb49d2ea1f0230af32070714ed2d97906a11e69423b355feeb2775717bb73683
IEDL.DBID M48
ISSN 1553-7374
1553-7366
IngestDate Fri Nov 26 17:14:12 EST 2021
Wed Aug 27 01:30:02 EDT 2025
Thu Aug 21 18:42:35 EDT 2025
Fri Sep 05 06:36:41 EDT 2025
Tue Jun 17 21:25:46 EDT 2025
Tue Jun 10 20:34:55 EDT 2025
Fri Jun 27 04:19:02 EDT 2025
Fri Jun 27 04:57:15 EDT 2025
Wed Feb 19 02:41:04 EST 2025
Thu Apr 24 23:03:29 EDT 2025
Tue Jul 01 02:41:09 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c699t-acb49d2ea1f0230af32070714ed2d97906a11e69423b355feeb2775717bb73683
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Conceived and designed the experiments: KEJ BC. Performed the experiments: KEJ VB SF SD VVS. Analyzed the data: KEJ BC. Wrote the paper: KEJ BC.
The authors have declared that no competing interests exist.
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.ppat.1004503
PMID 25375629
PQID 1622057903
PQPubID 23479
ParticipantIDs plos_journals_1685292398
doaj_primary_oai_doaj_org_article_7eeeef219b014e0bb9e27b21a2940146
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4223080
proquest_miscellaneous_1622057903
gale_infotracmisc_A393518091
gale_infotracacademiconefile_A393518091
gale_incontextgauss_ISR_A393518091
gale_incontextgauss_ISN_A393518091
pubmed_primary_25375629
crossref_citationtrail_10_1371_journal_ppat_1004503
crossref_primary_10_1371_journal_ppat_1004503
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-11-01
PublicationDateYYYYMMDD 2014-11-01
PublicationDate_xml – month: 11
  year: 2014
  text: 2014-11-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco, USA
PublicationTitle PLoS pathogens
PublicationTitleAlternate PLoS Pathog
PublicationYear 2014
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References CJ Liu (ref73) 2005; 280
Y Luan (ref74) 2007; 282
KE Johnson (ref26) 2008; 374
RW Johnstone (ref33) 2000; 19
BA McNally (ref102) 2008; 3
JC Kwak (ref34) 2003; 278
C Diaz-Latoud (ref84) 1997; 2
B Chaigne-Delalande (ref90) 2006; 168
VV Singh (ref93) 2014; 88
M Kalamvoki (ref47) 2014; 111
T Li (ref37) 2012; 109
RJ Whitley (ref4) 1982; 247
Y Amrani (ref72) 2003; 284
JA Trapani (ref30) 1992; 36
GR Gariano (ref45) 2012; 8
LL Song (ref75) 2010; 5
B Altinkilic (ref51) 1988; 69
CA Spencer (ref60) 2000; 150
AV Chee (ref27) 2004; 78
V Brazda (ref29) 2012; 422
KA Cassady (ref83) 1998; 72
M Lussignol (ref88) 2013; 87
H Gu (ref18) 2007; 104
MH Hancock (ref14) 2010; 84
GN Barber (ref78) 2011; 12
B Dauber (ref9) 2011; 85
GP Zambetti (ref92) 1992; 89
SL Deshmane (ref15) 1989; 63
MH Orzalli (ref38) 2013; 110
KA Jones (ref64) 1985; 317
IM Cristea (ref70) 2010; 84
WJ Cook (ref101) 2004; 1
A Shah (ref68) 2010; 16
AA Oroskar (ref8) 1989; 63
DM Knipe (ref95) 1982; 43
JT Lester (ref59) 2011; 85
Y Shang (ref99) 2000; 103
L Unterholzner (ref28) 2010; 11
KM Monroe (ref69) 2014; 343
H Tawara (ref35) 2008; 13
M Duc Dodon (ref86) 2000; 270
MA Ansari (ref40) 2013; 87
GG Maul (ref21) 1994; 75
MH Orzalli (ref20) 2012; 109
S Mittnacht (ref52) 1988; 164
F Yao (ref82) 1995; 69
J Xing (ref87) 2012; 86
Y Maruzuru (ref63) 2013; 87
N Kerur (ref39) 2011; 9
KE Johnson (ref19) 2013; 87
D Pan (ref81) 2014; 15
RJ Whitley (ref3) 2002; 359
C Smith (ref56) 2014; 15
FJ Herrera (ref12) 2004; 78
X Duan (ref80) 2011; 6
S Fredriksson (ref58) 2002; 20
HJ Kang (ref76) 2014; 74
VV Singh (ref42) 2013; 87
RW Honess (ref6) 1975; 16
XL Li (ref50) 1998; 18
P Sampath (ref62) 2008; 82
K Rosenke (ref96) 2004; 78
S Yokota (ref24) 2001; 286
L Benboudjema (ref85) 2003; 77
RW Johnstone (ref71) 1999; 19
AD Kwong (ref7) 1987; 84
KE Boyd (ref98) 1999; 19
SC Stein (ref67) 2012; 86
RD Everett (ref49) 2008; 82
JA Aglipay (ref79) 2003; 22
V Hornung (ref53) 2009; 458
SG Swygert (ref17) 2014; 1839
WA Freed-Pastor (ref89) 2011; 10
G Tiscornia (ref97) 2006; 1
M Kalamvoki (ref100) 2010; 84
KE Johnson (ref25) 2010; 396
V Dell'oste (ref77) 2014; 88
B He (ref10) 1997; 71
JR Kent (ref11) 2004; 78
RW Johnstone (ref32) 1998; 273
KJ Livak (ref46) 2001; 25
EG Van Meir (ref91) 1995; 92
JA Trapani (ref31) 1994; 40
P Mali (ref54) 2013; 339
T Li (ref43) 2013; 14
X Wu (ref57) 2014; 32
ref1
D Cuchet-Lourenco (ref44) 2013; 87
RW Honess (ref5) 1974; 14
QY Wang (ref16) 2005; 102
T Jin (ref61) 2012; 36
DB Hall (ref66) 2002; 277
M Ouchi (ref36) 2008; 13
S Soby (ref94) 2012; 3
N Fujiuchi (ref48) 2004; 279
AR Cliffe (ref13) 2008; 82
GT Melroe (ref23) 2007; 360
MR Jakobsen (ref41) 2013; 110
GT Melroe (ref22) 2004; 78
A Veres (ref55) 2014; 15
JW Streilein (ref2) 1997; 18
S He (ref65) 1998; 18
14654789 - Oncogene. 2003 Dec 4;22(55):8931-8
19939931 - J Virol. 2010 Feb;84(3):1366-75
20052289 - PLoS One. 2010;5(1):e8569
6287005 - J Virol. 1982 Jul;43(1):314-24
1570319 - Proc Natl Acad Sci U S A. 1992 May 1;89(9):3952-6
24996165 - Cell Stem Cell. 2014 Jul 3;15(1):12-3
15331750 - J Virol. 2004 Sep;78(18):10178-86
11146555 - Oncogene. 2000 Dec 7;19(52):6033-42
2993923 - Nature. 1985 Sep 12-18;317(6033):179-82
17406239 - Nat Protoc. 2006;1(1):241-5
17939992 - Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17134-9
2834869 - Virology. 1988 May;164(1):201-10
11136970 - Cell. 2000 Dec 8;103(6):843-52
9566906 - Mol Cell Biol. 1998 May;18(5):2876-83
23388709 - J Virol. 2013 Apr;87(8):4417-31
24352470 - J Virol. 2014 Mar;88(5):2821-34
24449861 - Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):E611-7
22127203 - Cell Cycle. 2011 Dec 15;10(24):4207
18094162 - J Virol. 2008 Mar;82(5):2339-49
11853816 - Lancet. 2002 Feb 9;359(9305):507-13
2539493 - J Virol. 1989 May;63(5):1897-906
21573174 - PLoS One. 2011;6(5):e19532
12297514 - J Biol Chem. 2002 Nov 29;277(48):46043-50
4365321 - J Virol. 1974 Jul;14(1):8-19
18509536 - PLoS One. 2008;3(5):e2277
18842720 - J Virol. 2008 Dec;82(24):12030-8
24752079 - Nat Biotechnol. 2014 Jul;32(7):670-6
15331701 - J Virol. 2004 Sep;78(18):9689-96
24198334 - Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):E4492-501
2536115 - J Virol. 1989 Feb;63(2):943-7
20504932 - J Virol. 2010 Aug;84(15):7803-14
24356113 - Science. 2014 Jan 24;343(6169):428-32
20890285 - Nat Immunol. 2010 Nov;11(11):997-1004
21934672 - Nat Immunol. 2011 Oct;12(10):929-30
14990579 - J Biol Chem. 2004 May 7;279(19):20339-44
171454 - J Virol. 1975 Nov;16(5):1308-26
18579584 - J Virol. 2008 Sep;82(17):8871-81
21450820 - J Virol. 2011 Jun;85(12):5733-44
10454530 - Mol Cell Biol. 1999 Sep;19(9):5833-8
12915535 - J Virol. 2003 Sep;77(17):9192-203
24996167 - Cell Stem Cell. 2014 Jul 3;15(1):27-30
23062757 - Herpesviridae. 2012 Oct 14;3(1):6
1526658 - Immunogenetics. 1992;36(6):369-76
9765401 - J Virol. 1998 Nov;72(11):8620-6
3031658 - Proc Natl Acad Sci U S A. 1987 Apr;84(7):1926-30
7862624 - Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1008-12
7666525 - J Virol. 1995 Oct;69(10):6249-58
24583555 - Biochim Biophys Acta. 2014 Aug;1839(8):728-36
24154727 - Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):E4571-80
10567564 - Mol Cell Biol. 1999 Dec;19(12):8393-9
20660182 - J Virol. 2010 Oct;84(19):9709-17
17439944 - J Biol Chem. 2007 Jun 8;282(23):16860-70
10893252 - J Cell Biol. 2000 Jul 10;150(1):13-26
12588705 - Am J Physiol Lung Cell Mol Physiol. 2003 Jun;284(6):L1063-71
8207389 - J Gen Virol. 1994 Jun;75 ( Pt 6):1223-33
22618232 - Biochem Biophys Res Commun. 2012 Jun 15;422(4):716-20
24089555 - J Virol. 2013 Dec;87(24):13422-32
6275134 - JAMA. 1982 Jan 15;247(3):317-20
23785201 - J Virol. 2013 Aug;87(16):9323-32
16436670 - Am J Pathol. 2006 Feb;168(2):562-73
24696486 - J Virol. 2014 Jun;88(12):6970-82
23115300 - J Virol. 2013 Jan;87(2):859-71
18279905 - Virology. 2008 May 10;374(2):487-94
21139972 - Mol Vis. 2010;16:2476-86
22345436 - J Virol. 2012 Apr;86(8):4527-37
23287722 - Science. 2013 Feb 15;339(6121):823-6
11981560 - Nat Biotechnol. 2002 May;20(5):473-7
22291595 - PLoS Pathog. 2012 Jan;8(1):e1002498
17981542 - Front Biosci. 2008;13:240-8
21430045 - J Virol. 2011 Jun;85(11):5363-73
23720728 - J Virol. 2013 Aug;87(15):8606-23
19879619 - Virology. 2010 Jan 5;396(1):21-9
9250403 - Cell Stress Chaperones. 1997 Jun;2(2):119-31
9642285 - J Biol Chem. 1998 Jul 3;273(27):17172-7
24721573 - Cell Host Microbe. 2014 Apr 9;15(4):446-56
22691496 - Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10558-63
17126870 - Virology. 2007 Apr 10;360(2):305-21
7959953 - Immunogenetics. 1994;40(6):415-24
22483801 - Immunity. 2012 Apr 20;36(4):561-71
15220456 - J Virol. 2004 Jul;78(14):7818-22
24413532 - Cancer Res. 2014 Mar 1;74(5):1484-94
15507126 - Virol J. 2004;1:5
2848929 - J Gen Virol. 1988 Dec;69 ( Pt 12):3107-12
11846609 - Methods. 2001 Dec;25(4):402-8
15047834 - J Virol. 2004 Apr;78(8):4185-96
10772978 - Virology. 2000 Apr 25;270(1):43-53
17981541 - Front Biosci. 2008;13:236-9
19158675 - Nature. 2009 Mar 26;458(7237):514-8
9293161 - Immunol Today. 1997 Sep;18(9):443-9
23027953 - Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):E3008-17
9223497 - J Virol. 1997 Aug;71(8):6049-54
21575908 - Cell Host Microbe. 2011 May 19;9(5):363-75
9858316 - J Interferon Cytokine Res. 1998 Nov;18(11):947-52
24237704 - Cell Host Microbe. 2013 Nov 13;14(5):591-9
15557274 - J Biol Chem. 2005 Jan 28;280(4):2788-96
12925527 - J Biol Chem. 2003 Oct 17;278(42):40899-904
15280450 - J Virol. 2004 Aug;78(16):8411-20
11448165 - Virology. 2001 Jul 20;286(1):119-24
22301138 - J Virol. 2012 Apr;86(7):3528-40
23427152 - J Virol. 2013 May;87(9):5005-18
29874275 - PLoS Pathog. 2018 Jun 6;14 (6):e1007113
16247011 - Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16055-9
References_xml – ident: ref1
– volume: 2
  start-page: 119
  year: 1997
  ident: ref84
  article-title: Herpes simplex virus Us11 protein enhances recovery of protein synthesis and survival in heat shock treated HeLa cells
  publication-title: Cell Stress Chaperones
  doi: 10.1379/1466-1268(1997)002<0119:HSVUPE>2.3.CO;2
– volume: 87
  start-page: 9323
  year: 2013
  ident: ref63
  article-title: Roles of p53 in herpes simplex virus 1 replication
  publication-title: J Virol
  doi: 10.1128/JVI.01581-13
– volume: 164
  start-page: 201
  year: 1988
  ident: ref52
  article-title: Interferon treatment inhibits onset of herpes simplex virus immediate-early transcription
  publication-title: Virology
  doi: 10.1016/0042-6822(88)90637-X
– volume: 92
  start-page: 1008
  year: 1995
  ident: ref91
  article-title: Single cell monitoring of growth arrest and morphological changes induced by transfer of wild-type p53 alleles to glioblastoma cells
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.92.4.1008
– volume: 11
  start-page: 997
  year: 2010
  ident: ref28
  article-title: IFI16 is an innate immune sensor for intracellular DNA
  publication-title: Nat Immunol
  doi: 10.1038/ni.1932
– volume: 78
  start-page: 9689
  year: 2004
  ident: ref12
  article-title: VP16-dependent association of chromatin-modifying coactivators and underrepresentation of histones at immediate-early gene promoters during herpes simplex virus infection
  publication-title: J Virol
  doi: 10.1128/JVI.78.18.9689-9696.2004
– volume: 339
  start-page: 823
  year: 2013
  ident: ref54
  article-title: RNA-guided human genome engineering via Cas9
  publication-title: Science
  doi: 10.1126/science.1232033
– volume: 343
  start-page: 428
  year: 2014
  ident: ref69
  article-title: IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV
  publication-title: Science
  doi: 10.1126/science.1243640
– volume: 8
  start-page: e1002498
  year: 2012
  ident: ref45
  article-title: The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1002498
– volume: 374
  start-page: 487
  year: 2008
  ident: ref26
  article-title: Role for herpes simplex virus 1 ICP27 in the inhibition of type I interferon signaling
  publication-title: Virology
  doi: 10.1016/j.virol.2008.01.001
– volume: 10
  start-page: 4207
  year: 2011
  ident: ref89
  article-title: Dissimilar DNA binding by p53 in normal and tumor-derived cells
  publication-title: Cell Cycle
  doi: 10.4161/cc.10.24.18723
– volume: 396
  start-page: 21
  year: 2010
  ident: ref25
  article-title: Herpes simplex virus-1 infection causes the secretion of a type I interferon-antagonizing protein and inhibits signaling at or before Jak-1 activation
  publication-title: Virology
  doi: 10.1016/j.virol.2009.09.021
– volume: 270
  start-page: 43
  year: 2000
  ident: ref86
  article-title: The herpes simplex virus 1 Us11 protein cooperates with suboptimal amounts of human immunodeficiency virus type 1 (HIV-1) Rev protein to rescue HIV-1 production
  publication-title: Virology
  doi: 10.1006/viro.2000.0275
– volume: 1839
  start-page: 728
  year: 2014
  ident: ref17
  article-title: Chromatin dynamics: Interplay between remodeling enzymes and histone modifications
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbagrm.2014.02.013
– volume: 109
  start-page: 10558
  year: 2012
  ident: ref37
  article-title: Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1203447109
– volume: 25
  start-page: 402
  year: 2001
  ident: ref46
  article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
  publication-title: Methods
  doi: 10.1006/meth.2001.1262
– volume: 3
  start-page: e2277
  year: 2008
  ident: ref102
  article-title: A role for cytoplasmic PML in cellular resistance to viral infection
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0002277
– volume: 15
  start-page: 446
  year: 2014
  ident: ref81
  article-title: A Neuron-Specific Host MicroRNA Targets Herpes Simplex Virus-1 ICP0 Expression and Promotes Latency
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2014.03.004
– volume: 102
  start-page: 16055
  year: 2005
  ident: ref16
  article-title: Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0505850102
– volume: 16
  start-page: 2476
  year: 2010
  ident: ref68
  article-title: HSV-1 infection of human corneal epithelial cells: receptor-mediated entry and trends of re-infection
  publication-title: Mol Vis
– volume: 1
  start-page: 241
  year: 2006
  ident: ref97
  article-title: Production and purification of lentiviral vectors
  publication-title: Nat Protoc
  doi: 10.1038/nprot.2006.37
– volume: 77
  start-page: 9192
  year: 2003
  ident: ref85
  article-title: Association of the herpes simplex virus type 1 Us11 gene product with the cellular kinesin light-chain-related protein PAT1 results in the redistribution of both polypeptides
  publication-title: J Virol
  doi: 10.1128/JVI.77.17.9192-9203.2003
– volume: 19
  start-page: 8393
  year: 1999
  ident: ref98
  article-title: Coexamination of site-specific transcription factor binding and promoter activity in living cells
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.19.12.8393
– volume: 72
  start-page: 8620
  year: 1998
  ident: ref83
  article-title: The herpes simplex virus US11 protein effectively compensates for the gamma1(34.5) gene if present before activation of protein kinase R by precluding its phosphorylation and that of the alpha subunit of eukaryotic translation initiation factor 2
  publication-title: J Virol
  doi: 10.1128/JVI.72.11.8620-8626.1998
– volume: 89
  start-page: 3952
  year: 1992
  ident: ref92
  article-title: A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.89.9.3952
– volume: 78
  start-page: 7818
  year: 2004
  ident: ref96
  article-title: Bromodeoxyuridine-labeled viral particles as a tool for visualization of the immediate-early events of human cytomegalovirus infection
  publication-title: J Virol
  doi: 10.1128/JVI.78.14.7818-7822.2004
– volume: 84
  start-page: 7803
  year: 2010
  ident: ref70
  article-title: Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein
  publication-title: J Virol
  doi: 10.1128/JVI.00139-10
– volume: 78
  start-page: 8411
  year: 2004
  ident: ref22
  article-title: Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production
  publication-title: J Virol
  doi: 10.1128/JVI.78.16.8411-8420.2004
– volume: 86
  start-page: 3528
  year: 2012
  ident: ref87
  article-title: Herpes simplex virus 1 tegument protein US11 downmodulates the RLR signaling pathway via direct interaction with RIG-I and MDA-5
  publication-title: J Virol
  doi: 10.1128/JVI.06713-11
– volume: 18
  start-page: 2876
  year: 1998
  ident: ref65
  article-title: Stepwise recruitment of components of the preinitiation complex by upstream activators in vivo
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.18.5.2876
– volume: 360
  start-page: 305
  year: 2007
  ident: ref23
  article-title: Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction
  publication-title: Virology
  doi: 10.1016/j.virol.2006.10.028
– volume: 284
  start-page: L1063
  year: 2003
  ident: ref72
  article-title: IFN-gamma inhibits human airway smooth muscle cell proliferation by modulating the E2F-1/Rb pathway
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00363.2002
– volume: 286
  start-page: 119
  year: 2001
  ident: ref24
  article-title: Herpes simplex virus type 1 suppresses the interferon signaling pathway by inhibiting phosphorylation of STATs and janus kinases during an early infection stage
  publication-title: Virology
  doi: 10.1006/viro.2001.0941
– volume: 277
  start-page: 46043
  year: 2002
  ident: ref66
  article-title: The VP16 activation domain interacts with multiple transcriptional components as determined by protein-protein cross-linking in vivo
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M208911200
– volume: 15
  start-page: 27
  year: 2014
  ident: ref55
  article-title: Low incidence of off-target mutations in individual CRISPR-Cas9 and TALEN targeted human stem cell clones detected by whole-genome sequencing
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2014.04.020
– volume: 87
  start-page: 8606
  year: 2013
  ident: ref40
  article-title: Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells
  publication-title: J Virol
  doi: 10.1128/JVI.00805-13
– volume: 6
  start-page: e19532
  year: 2011
  ident: ref80
  article-title: IFI16 induction by glucose restriction in human fibroblasts contributes to autophagy through activation of the ATM/AMPK/p53 pathway
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0019532
– volume: 458
  start-page: 514
  year: 2009
  ident: ref53
  article-title: AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC
  publication-title: Nature
  doi: 10.1038/nature07725
– volume: 280
  start-page: 2788
  year: 2005
  ident: ref73
  article-title: The interferon-inducible p204 protein acts as a transcriptional coactivator of Cbfa1 and enhances osteoblast differentiation
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M412604200
– volume: 86
  start-page: 4527
  year: 2012
  ident: ref67
  article-title: Sensing adenovirus infection: activation of interferon regulatory factor 3 in RAW 264.7 cells
  publication-title: J Virol
  doi: 10.1128/JVI.07071-11
– volume: 71
  start-page: 6049
  year: 1997
  ident: ref10
  article-title: Suppression of the phenotype of gamma(1)34.5- herpes simplex virus 1: failure of activated RNA-dependent protein kinase to shut off protein synthesis is associated with a deletion in the domain of the alpha47 gene
  publication-title: J Virol
  doi: 10.1128/JVI.71.8.6049-6054.1997
– volume: 40
  start-page: 415
  year: 1994
  ident: ref31
  article-title: Genomic organization of IFI16, an interferon-inducible gene whose expression is associated with human myeloid cell differentiation: correlation of predicted protein domains with exon organization
  publication-title: Immunogenetics
  doi: 10.1007/BF00177824
– volume: 14
  start-page: 591
  year: 2013
  ident: ref43
  article-title: Human cytomegalovirus tegument protein pUL83 inhibits IFI16-mediated DNA sensing for immune evasion
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2013.10.007
– volume: 87
  start-page: 4417
  year: 2013
  ident: ref42
  article-title: Kaposi's Sarcoma-Associated Herpesvirus Latency in Endothelial and B cells Activates Interferon Gamma-Inducible Protein 16 (IFI16) Mediated Inflammasomes
  publication-title: J Virol
  doi: 10.1128/JVI.03282-12
– volume: 88
  start-page: 6970
  year: 2014
  ident: ref77
  article-title: Innate nuclear sensor IFI16 translocates into the cytoplasm during early stage of in vitro HCMV infection and is entrapped in the egressing virions during late stage
  publication-title: J Virol
  doi: 10.1128/JVI.00384-14
– volume: 14
  start-page: 8
  year: 1974
  ident: ref5
  article-title: Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins
  publication-title: J Virol
  doi: 10.1128/JVI.14.1.8-19.1974
– volume: 69
  start-page: 3107
  year: 1988
  ident: ref51
  article-title: Interferon inhibits herpes simplex virus-specific translation: a reinvestigation
  publication-title: J Gen Virol
  doi: 10.1099/0022-1317-69-12-3107
– volume: 36
  start-page: 369
  year: 1992
  ident: ref30
  article-title: A novel gene constitutively expressed in human lymphoid cells is inducible with interferon-gamma in myeloid cells
  publication-title: Immunogenetics
  doi: 10.1007/BF00218044
– volume: 22
  start-page: 8931
  year: 2003
  ident: ref79
  article-title: A member of the Pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1207057
– volume: 109
  start-page: E3008
  year: 2012
  ident: ref20
  article-title: Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1211302109
– volume: 279
  start-page: 20339
  year: 2004
  ident: ref48
  article-title: Requirement of IFI16 for the maximal activation of p53 induced by ionizing radiation
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M400344200
– volume: 282
  start-page: 16860
  year: 2007
  ident: ref74
  article-title: The retinoblastoma protein is an essential mediator of osteogenesis that links the p204 protein to the Cbfa1 transcription factor thereby increasing its activity
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M610943200
– volume: 3
  start-page: 6
  year: 2012
  ident: ref94
  article-title: HSV-1-induced chemokine expression via IFI16-dependent and IFI16-independent pathways in human monocyte-derived macrophages
  publication-title: Herpesviridae
  doi: 10.1186/2042-4280-3-6
– volume: 13
  start-page: 236
  year: 2008
  ident: ref36
  article-title: Role of IFI16 in DNA damage and checkpoint
  publication-title: Front Biosci
  doi: 10.2741/2673
– volume: 87
  start-page: 13422
  year: 2013
  ident: ref44
  article-title: The viral ubiquitin ligase ICP0 is neither sufficient nor necessary for degradation of the cellular DNA sensor IFI16 during herpes simplex virus 1 infection
  publication-title: J Virol
  doi: 10.1128/JVI.02474-13
– volume: 18
  start-page: 947
  year: 1998
  ident: ref50
  article-title: Induction of interferon synthesis and activation of interferon-stimulated genes by liposomal transfection reagents
  publication-title: J Interferon Cytokine Res
  doi: 10.1089/jir.1998.18.947
– volume: 82
  start-page: 2339
  year: 2008
  ident: ref62
  article-title: Binding of ICP4, TATA-binding protein, and RNA polymerase II to herpes simplex virus type 1 immediate-early, early, and late promoters in virus-infected cells
  publication-title: J Virol
  doi: 10.1128/JVI.02459-07
– volume: 359
  start-page: 507
  year: 2002
  ident: ref3
  article-title: Viral encephalitis: familiar infections and emerging pathogens
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)07681-X
– volume: 104
  start-page: 17134
  year: 2007
  ident: ref18
  article-title: Herpes simplex virus-infected cell protein 0 blocks the silencing of viral DNA by dissociating histone deacetylases from the CoREST-REST complex
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0707266104
– volume: 78
  start-page: 4185
  year: 2004
  ident: ref27
  article-title: Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites
  publication-title: J Virol
  doi: 10.1128/JVI.78.8.4185-4196.2004
– volume: 69
  start-page: 6249
  year: 1995
  ident: ref82
  article-title: An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1
  publication-title: J Virol
  doi: 10.1128/JVI.69.10.6249-6258.1995
– volume: 87
  start-page: 5005
  year: 2013
  ident: ref19
  article-title: HSV-1 Infection Induces Activation and Subsequent Inhibition of the IFI16 and NLRP3 Inflammasomes
  publication-title: J Virol
  doi: 10.1128/JVI.00082-13
– volume: 9
  start-page: 363
  year: 2011
  ident: ref39
  article-title: IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection
  publication-title: Cell Host Microbe
  doi: 10.1016/j.chom.2011.04.008
– volume: 278
  start-page: 40899
  year: 2003
  ident: ref34
  article-title: IFI16 as a negative regulator in the regulation of p53 and p21(Waf1)
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M308012200
– volume: 36
  start-page: 561
  year: 2012
  ident: ref61
  article-title: Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor
  publication-title: Immunity
  doi: 10.1016/j.immuni.2012.02.014
– volume: 168
  start-page: 562
  year: 2006
  ident: ref90
  article-title: RhoGTPases and p53 are involved in the morphological appearance and interferon-alpha response of hairy cells
  publication-title: Am J Pathol
  doi: 10.2353/ajpath.2006.050345
– volume: 43
  start-page: 314
  year: 1982
  ident: ref95
  article-title: Definition of a series of stages in the association of two herpesviral proteins with the cell nucleus
  publication-title: J Virol
  doi: 10.1128/JVI.43.1.314-324.1982
– volume: 422
  start-page: 716
  year: 2012
  ident: ref29
  article-title: Preferential binding of IFI16 protein to cruciform structure and superhelical DNA
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2012.05.065
– volume: 103
  start-page: 843
  year: 2000
  ident: ref99
  article-title: Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)00188-4
– volume: 15
  start-page: 12
  year: 2014
  ident: ref56
  article-title: Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2014.06.011
– volume: 16
  start-page: 1308
  year: 1975
  ident: ref6
  article-title: Proteins specified by herpes simplex virus. XIII. Glycosylation of viral polypeptides
  publication-title: J Virol
  doi: 10.1128/JVI.16.5.1308-1326.1975
– volume: 5
  start-page: e8569
  year: 2010
  ident: ref75
  article-title: Interferon-inducible IFI16, a negative regulator of cell growth, down-regulates expression of human telomerase reverse transcriptase (hTERT) gene
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0008569
– volume: 13
  start-page: 240
  year: 2008
  ident: ref35
  article-title: Loss of p53-regulatory protein IFI16 induces NBS1 leading to activation of p53-mediated checkpoint by phosphorylation of p53 SER37
  publication-title: Front Biosci
  doi: 10.2741/2674
– volume: 75
  start-page: 1223
  year: 1994
  ident: ref21
  article-title: The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0
  publication-title: J Gen Virol
  doi: 10.1099/0022-1317-75-6-1223
– volume: 74
  start-page: 1484
  year: 2014
  ident: ref76
  article-title: Differential regulation of estrogen receptor alpha expression in breast cancer cells by metastasis-associated protein 1
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-13-2020
– volume: 317
  start-page: 179
  year: 1985
  ident: ref64
  article-title: Sp1 binds to promoter sequences and activates herpes simplex virus ‘immediate-early’ gene transcription in vitro
  publication-title: Nature
  doi: 10.1038/317179a0
– volume: 110
  start-page: E4571
  year: 2013
  ident: ref41
  article-title: IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1311669110
– volume: 85
  start-page: 5363
  year: 2011
  ident: ref9
  article-title: The herpes simplex virus 1 vhs protein enhances translation of viral true late mRNAs and virus production in a cell type-dependent manner
  publication-title: J Virol
  doi: 10.1128/JVI.00115-11
– volume: 78
  start-page: 10178
  year: 2004
  ident: ref11
  article-title: During lytic infection herpes simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription
  publication-title: J Virol
  doi: 10.1128/JVI.78.18.10178-10186.2004
– volume: 84
  start-page: 1366
  year: 2010
  ident: ref14
  article-title: Herpes simplex virus VP16, but not ICP0, is required to reduce histone occupancy and enhance histone acetylation on viral genomes in U2OS osteosarcoma cells
  publication-title: J Virol
  doi: 10.1128/JVI.01727-09
– volume: 1
  start-page: 5
  year: 2004
  ident: ref101
  article-title: Persistent expression of chemokine and chemokine receptor RNAs at primary and latent sites of herpes simplex virus 1 infection
  publication-title: Virol J
  doi: 10.1186/1743-422X-1-5
– volume: 82
  start-page: 8871
  year: 2008
  ident: ref49
  article-title: STAT-1- and IRF-3-dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts
  publication-title: J Virol
  doi: 10.1128/JVI.00613-08
– volume: 82
  start-page: 12030
  year: 2008
  ident: ref13
  article-title: Herpes simplex virus ICP0 promotes both histone removal and acetylation on viral DNA during lytic infection
  publication-title: J Virol
  doi: 10.1128/JVI.01575-08
– volume: 12
  start-page: 929
  year: 2011
  ident: ref78
  article-title: STING-dependent signaling
  publication-title: Nat Immunol
  doi: 10.1038/ni.2118
– volume: 84
  start-page: 1926
  year: 1987
  ident: ref7
  article-title: Herpes simplex virus-infected cells contain a function(s) that destabilizes both host and viral mRNAs
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.84.7.1926
– volume: 247
  start-page: 317
  year: 1982
  ident: ref4
  article-title: Herpes simplex encephalitis. Clinical Assessment
  publication-title: JAMA
  doi: 10.1001/jama.1982.03320280037026
– volume: 63
  start-page: 943
  year: 1989
  ident: ref15
  article-title: During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure
  publication-title: J Virol
  doi: 10.1128/JVI.63.2.943-947.1989
– volume: 85
  start-page: 5733
  year: 2011
  ident: ref59
  article-title: Herpes simplex virus 1 ICP4 forms complexes with TFIID and mediator in virus-infected cells
  publication-title: J Virol
  doi: 10.1128/JVI.00385-11
– volume: 111
  start-page: E611
  year: 2014
  ident: ref47
  article-title: HSV-1 degrades, stabilizes, requires, or is stung by STING depending on ICP0, the US3 protein kinase, and cell derivation
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1323414111
– volume: 18
  start-page: 443
  year: 1997
  ident: ref2
  article-title: Immunity causing blindness: five different paths to herpes stromal keratitis
  publication-title: Immunol Today
  doi: 10.1016/S0167-5699(97)01114-6
– volume: 19
  start-page: 5833
  year: 1999
  ident: ref71
  article-title: Transcription and growth regulatory functions of the HIN-200 family of proteins
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.19.9.5833
– volume: 150
  start-page: 13
  year: 2000
  ident: ref60
  article-title: Mitotic transcription repression in vivo in the absence of nucleosomal chromatin condensation
  publication-title: J Cell Biol
  doi: 10.1083/jcb.150.1.13
– volume: 273
  start-page: 17172
  year: 1998
  ident: ref32
  article-title: The human interferon-inducible protein, IFI 16, is a repressor of transcription
  publication-title: J Biol Chem
  doi: 10.1074/jbc.273.27.17172
– volume: 19
  start-page: 6033
  year: 2000
  ident: ref33
  article-title: Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1204005
– volume: 87
  start-page: 859
  year: 2013
  ident: ref88
  article-title: The herpes simplex virus 1 Us11 protein inhibits autophagy through its interaction with the protein kinase PKR
  publication-title: J Virol
  doi: 10.1128/JVI.01158-12
– volume: 84
  start-page: 9709
  year: 2010
  ident: ref100
  article-title: Interwoven roles of cyclin D3 and cdk4 recruited by ICP0 and ICP4 in the expression of herpes simplex virus genes
  publication-title: J Virol
  doi: 10.1128/JVI.01050-10
– volume: 32
  start-page: 670
  year: 2014
  ident: ref57
  article-title: Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.2889
– volume: 88
  start-page: 2821
  year: 2014
  ident: ref93
  article-title: Kaposi's sarcoma-associated herpesvirus induces the ATM and H2AX DNA damage response early during de novo infection of primary endothelial cells, which play roles in latency establishment
  publication-title: J Virol
  doi: 10.1128/JVI.03126-13
– volume: 63
  start-page: 1897
  year: 1989
  ident: ref8
  article-title: Control of mRNA stability by the virion host shutoff function of herpes simplex virus
  publication-title: J Virol
  doi: 10.1128/JVI.63.5.1897-1906.1989
– volume: 20
  start-page: 473
  year: 2002
  ident: ref58
  article-title: Protein detection using proximity-dependent DNA ligation assays
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt0502-473
– volume: 110
  start-page: E4492
  year: 2013
  ident: ref38
  article-title: Nuclear interferon-inducible protein 16 promotes silencing of herpesviral and transfected DNA
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.1316194110
– reference: 18509536 - PLoS One. 2008;3(5):e2277
– reference: 15507126 - Virol J. 2004;1:5
– reference: 8207389 - J Gen Virol. 1994 Jun;75 ( Pt 6):1223-33
– reference: 171454 - J Virol. 1975 Nov;16(5):1308-26
– reference: 10772978 - Virology. 2000 Apr 25;270(1):43-53
– reference: 24413532 - Cancer Res. 2014 Mar 1;74(5):1484-94
– reference: 23062757 - Herpesviridae. 2012 Oct 14;3(1):6
– reference: 9223497 - J Virol. 1997 Aug;71(8):6049-54
– reference: 24154727 - Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):E4571-80
– reference: 20504932 - J Virol. 2010 Aug;84(15):7803-14
– reference: 23427152 - J Virol. 2013 May;87(9):5005-18
– reference: 24721573 - Cell Host Microbe. 2014 Apr 9;15(4):446-56
– reference: 7862624 - Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1008-12
– reference: 23388709 - J Virol. 2013 Apr;87(8):4417-31
– reference: 15331750 - J Virol. 2004 Sep;78(18):10178-86
– reference: 22483801 - Immunity. 2012 Apr 20;36(4):561-71
– reference: 22301138 - J Virol. 2012 Apr;86(7):3528-40
– reference: 7666525 - J Virol. 1995 Oct;69(10):6249-58
– reference: 6275134 - JAMA. 1982 Jan 15;247(3):317-20
– reference: 17981541 - Front Biosci. 2008;13:236-9
– reference: 19879619 - Virology. 2010 Jan 5;396(1):21-9
– reference: 18094162 - J Virol. 2008 Mar;82(5):2339-49
– reference: 21139972 - Mol Vis. 2010;16:2476-86
– reference: 24237704 - Cell Host Microbe. 2013 Nov 13;14(5):591-9
– reference: 2993923 - Nature. 1985 Sep 12-18;317(6033):179-82
– reference: 11853816 - Lancet. 2002 Feb 9;359(9305):507-13
– reference: 17939992 - Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17134-9
– reference: 10893252 - J Cell Biol. 2000 Jul 10;150(1):13-26
– reference: 24089555 - J Virol. 2013 Dec;87(24):13422-32
– reference: 18842720 - J Virol. 2008 Dec;82(24):12030-8
– reference: 22618232 - Biochem Biophys Res Commun. 2012 Jun 15;422(4):716-20
– reference: 9566906 - Mol Cell Biol. 1998 May;18(5):2876-83
– reference: 24752079 - Nat Biotechnol. 2014 Jul;32(7):670-6
– reference: 23287722 - Science. 2013 Feb 15;339(6121):823-6
– reference: 23027953 - Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):E3008-17
– reference: 10567564 - Mol Cell Biol. 1999 Dec;19(12):8393-9
– reference: 15331701 - J Virol. 2004 Sep;78(18):9689-96
– reference: 21575908 - Cell Host Microbe. 2011 May 19;9(5):363-75
– reference: 20890285 - Nat Immunol. 2010 Nov;11(11):997-1004
– reference: 2834869 - Virology. 1988 May;164(1):201-10
– reference: 22127203 - Cell Cycle. 2011 Dec 15;10(24):4207
– reference: 29874275 - PLoS Pathog. 2018 Jun 6;14 (6):e1007113
– reference: 24583555 - Biochim Biophys Acta. 2014 Aug;1839(8):728-36
– reference: 2848929 - J Gen Virol. 1988 Dec;69 ( Pt 12):3107-12
– reference: 22691496 - Proc Natl Acad Sci U S A. 2012 Jun 26;109(26):10558-63
– reference: 20052289 - PLoS One. 2010;5(1):e8569
– reference: 9293161 - Immunol Today. 1997 Sep;18(9):443-9
– reference: 9765401 - J Virol. 1998 Nov;72(11):8620-6
– reference: 15047834 - J Virol. 2004 Apr;78(8):4185-96
– reference: 24198334 - Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):E4492-501
– reference: 18279905 - Virology. 2008 May 10;374(2):487-94
– reference: 6287005 - J Virol. 1982 Jul;43(1):314-24
– reference: 12925527 - J Biol Chem. 2003 Oct 17;278(42):40899-904
– reference: 20660182 - J Virol. 2010 Oct;84(19):9709-17
– reference: 23785201 - J Virol. 2013 Aug;87(16):9323-32
– reference: 16436670 - Am J Pathol. 2006 Feb;168(2):562-73
– reference: 15220456 - J Virol. 2004 Jul;78(14):7818-22
– reference: 11448165 - Virology. 2001 Jul 20;286(1):119-24
– reference: 11981560 - Nat Biotechnol. 2002 May;20(5):473-7
– reference: 7959953 - Immunogenetics. 1994;40(6):415-24
– reference: 11146555 - Oncogene. 2000 Dec 7;19(52):6033-42
– reference: 17406239 - Nat Protoc. 2006;1(1):241-5
– reference: 1526658 - Immunogenetics. 1992;36(6):369-76
– reference: 21934672 - Nat Immunol. 2011 Oct;12(10):929-30
– reference: 21450820 - J Virol. 2011 Jun;85(12):5733-44
– reference: 15557274 - J Biol Chem. 2005 Jan 28;280(4):2788-96
– reference: 24996167 - Cell Stem Cell. 2014 Jul 3;15(1):27-30
– reference: 21573174 - PLoS One. 2011;6(5):e19532
– reference: 17126870 - Virology. 2007 Apr 10;360(2):305-21
– reference: 4365321 - J Virol. 1974 Jul;14(1):8-19
– reference: 16247011 - Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16055-9
– reference: 21430045 - J Virol. 2011 Jun;85(11):5363-73
– reference: 22345436 - J Virol. 2012 Apr;86(8):4527-37
– reference: 22291595 - PLoS Pathog. 2012 Jan;8(1):e1002498
– reference: 12297514 - J Biol Chem. 2002 Nov 29;277(48):46043-50
– reference: 24356113 - Science. 2014 Jan 24;343(6169):428-32
– reference: 1570319 - Proc Natl Acad Sci U S A. 1992 May 1;89(9):3952-6
– reference: 24996165 - Cell Stem Cell. 2014 Jul 3;15(1):12-3
– reference: 3031658 - Proc Natl Acad Sci U S A. 1987 Apr;84(7):1926-30
– reference: 24449861 - Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):E611-7
– reference: 19939931 - J Virol. 2010 Feb;84(3):1366-75
– reference: 17439944 - J Biol Chem. 2007 Jun 8;282(23):16860-70
– reference: 2539493 - J Virol. 1989 May;63(5):1897-906
– reference: 9250403 - Cell Stress Chaperones. 1997 Jun;2(2):119-31
– reference: 9858316 - J Interferon Cytokine Res. 1998 Nov;18(11):947-52
– reference: 14654789 - Oncogene. 2003 Dec 4;22(55):8931-8
– reference: 11846609 - Methods. 2001 Dec;25(4):402-8
– reference: 12588705 - Am J Physiol Lung Cell Mol Physiol. 2003 Jun;284(6):L1063-71
– reference: 24352470 - J Virol. 2014 Mar;88(5):2821-34
– reference: 14990579 - J Biol Chem. 2004 May 7;279(19):20339-44
– reference: 9642285 - J Biol Chem. 1998 Jul 3;273(27):17172-7
– reference: 12915535 - J Virol. 2003 Sep;77(17):9192-203
– reference: 23115300 - J Virol. 2013 Jan;87(2):859-71
– reference: 11136970 - Cell. 2000 Dec 8;103(6):843-52
– reference: 23720728 - J Virol. 2013 Aug;87(15):8606-23
– reference: 19158675 - Nature. 2009 Mar 26;458(7237):514-8
– reference: 17981542 - Front Biosci. 2008;13:240-8
– reference: 15280450 - J Virol. 2004 Aug;78(16):8411-20
– reference: 10454530 - Mol Cell Biol. 1999 Sep;19(9):5833-8
– reference: 2536115 - J Virol. 1989 Feb;63(2):943-7
– reference: 18579584 - J Virol. 2008 Sep;82(17):8871-81
– reference: 24696486 - J Virol. 2014 Jun;88(12):6970-82
SSID ssj0041316
Score 2.4813669
Snippet Interferon-γ inducible factor 16 (IFI16) is a multifunctional nuclear protein involved in transcriptional regulation, induction of interferon-β (IFN-β), and...
  Interferon-γ inducible factor 16 (IFI16) is a multifunctional nuclear protein involved in transcriptional regulation, induction of interferon-β (IFN-β), and...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e1004503
SubjectTerms Biology and Life Sciences
Bone cancer
Cell Line, Tumor
Colleges & universities
Deoxyribonucleic acid
DNA
Experiments
Gene expression
Gene Expression Regulation, Viral
Genetic aspects
Genome, Viral
Genomes
Health aspects
HEK293 Cells
Herpes simplex virus
Herpes viruses
Herpesvirus 1, Human - physiology
Histones
Histones - genetics
Histones - metabolism
Humans
Infections
Interferon
Microscopy
Nuclear Proteins - genetics
Nuclear Proteins - metabolism
Phosphoproteins - genetics
Phosphoproteins - metabolism
Protein Processing, Post-Translational
Protein research
Proteins
RNA polymerase
Transcription factors
Viral Proteins - biosynthesis
Viral Proteins - genetics
Virus Replication
Virus research
SummonAdditionalLinks – databaseName: DOAJ Open Access Full Text
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELZQJSReEL9XGMggJF4WFjuuXT8ORNUisQfG0N4sO3G2SW1SNS2i_w9_KHexEy0ItBf6lviSynfn8-f4_B0hb6cwpwOqlQm3YAbBizKZOpkm1qbC5aWFQYaHk7-cyvm5-HwxubhR6gtzwgI9cFDcsfLwK2FcOQDzPnVOe64cZ5ZrgcQnGH1TnXaLqRCDITK3RU-xKE6iMinjoblMseNoo_frtUX6aIA0XcGsOCm13P19hB6tl3XzN_j5ZxbljWlp9oDcj3iSnoR-PCR3fPWI3A0VJvePya_FbMEkxQIcEPC2DZ2ffU8YXPfb1tTtqc3z3aqt41VdUrgFoJBeNT9AEClcV_6IbmLCLLSHN0CDp_5nTKOtjqitChrmx-We1huKe-HxalUX3ctbemN4Em5hjlL4XPiEnM8-ffs4T2JhhiSXWm8TmzuhC-4tK3EJY8uMI2sQ2KfghVY6lZYxLzVANQd4pvSwfFdqAitH58Aa0-wpGVXwZweEloVXVkxY7qeF4E65HAEsfpxNU-tFOiZZZxmTR9ZyLJ6xNO1WnILVS1C0QXuaaM8xSfqn1oG14xb5D2j0XhY5t9sb4IkmeqK5zRPH5A26jEFWjQrTdi7trmnM4uzUnOABaGRKY_8U-joQeheFyho6m9t4VAJUhmxdA8nDgSTEhnzQfIDu2_W5MUzC4NTI-TgmrzuXNvgU5tpVvt6hDB6-BiuCWp4FF-8VwyeZAsSsx0QNnH-guWFLdX3VspYLAKKwPHn-P1T9gtwD4CrCmdBDMtpudv4lgMOte9XGgd8-lGH7
  priority: 102
  providerName: Directory of Open Access Journals
Title IFI16 Restricts HSV-1 Replication by Accumulating on the HSV-1 Genome, Repressing HSV-1 Gene Expression, and Directly or Indirectly Modulating Histone Modifications
URI https://www.ncbi.nlm.nih.gov/pubmed/25375629
https://www.proquest.com/docview/1622057903
https://pubmed.ncbi.nlm.nih.gov/PMC4223080
https://doaj.org/article/7eeeef219b014e0bb9e27b21a2940146
http://dx.doi.org/10.1371/journal.ppat.1004503
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fa9swEBddymAvY_-brQvaGOylLpajSPHDGOlIlgwSRrqMvAnJltNBamdxAs332QfdnS2bebQMljdbd3Z8d5LuJN3vCHnXhzkdvFrhBRrUwIM48fpG-J7WPjdRoqGTYXLydCbGC_5l2VsekapmqxNgfmtoh_WkFtv1-c3Pw0fo8B-Kqg2SVUznm41GQGhwUhD-8xjmJoHh2JTX-wowYhfFULFYjie7QrhkurueglDBva4EHyFszFsFvH89iLc26yy_zUP9-6DlHzPX6BF56FxOOiht5DE5sukTcr8sQnl4Sn5NRhMm6NxiBY9ol9Px5XePwXW9s03NgQ6iaH9dlPpKVxRugd_oCD_bNLu2Z8hQnKmF9rrB0uGNO2mbnlGdxrQcYtcHmm3pJI2rq2kWVw8vgEuAE27hMaZyRfEZWYyG3z6NPVe7wYtEGO48HRkexoHVLMEoRyfdAIGFGLdxEIcy9IVmzIoQvDkDLk9iIcKXsgfBpTGgmH73OWml8LITQpPYSs17LLL9mAdGmgh9XFy_9X1tud8m3UozKnLA5lhfY62K3ToJAU4paIWqVU61beLVXJsS2OMf9Beo9JoWYbmLG9l2pVwvV9LCL4FJAP4dt74xoQ2kCZgOQo4oPW3yFk1GIfBGiid7Vnqf52pyOVMDzJFGMDV2J9G8QfTeESUZfGykXTYFiAwBvRqUpw1KGD6iRvMJmm_1zbliAvpviLCQbfKmMmmFXHgcL7XZHmkwPxu0CGJ5UZp4LZiqw7SJbBh_Q3LNlvTHVQFszsFXhQjm5X9zviIPwKHlZa7oKWnttnv7GpzGnemQe3IpO-T4Yjj7Ou8USy-dYmz4Df73bjE
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IFI16+Restricts+HSV-1+Replication+by+Accumulating+on+the+HSV-1+Genome%2C+Repressing+HSV-1+Gene+Expression%2C+and+Directly+or+Indirectly+Modulating+Histone+Modifications&rft.jtitle=PLoS+pathogens&rft.au=Johnson%2C+Karen+E.&rft.au=Bottero%2C+Virginie&rft.au=Flaherty%2C+Stephanie&rft.au=Dutta%2C+Sujoy&rft.date=2014-11-01&rft.pub=Public+Library+of+Science&rft.issn=1553-7366&rft.eissn=1553-7374&rft.volume=10&rft.issue=11&rft_id=info:doi/10.1371%2Fjournal.ppat.1004503&rft_id=info%3Apmid%2F25375629&rft.externalDocID=PMC4223080
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1553-7374&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1553-7374&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1553-7374&client=summon